Citations

Clear

9383 citation(s) found for "Thomas, PS".

Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Aisen, Paul, Beckett, Laurel , Bennett, David A. , Craft, Suzanne , Fagan, Anne M. , Iwatsubo, Takeshi , Jack, Clifford R. , Kaye, Jeffrey , Montine, Thomas J. , Park, Denise C. , Reiman, Eric M. , Siemers, Eric , Stern, Yaakov , Yaffe, Kristine , Carrillo, María C. , Thies, Bill, Morrison‐Bogorad, Marcelle, Wagster, Molly V., Phelps, Creighton H., Sperling, Reisa Anne , Rowe, Christopher Cleon , Bennett, David A. , Jack, Clifford R , Stern, Yaakov

Mayo Clinic

Alzheimer's & Dementia | April 22, 2011 | Volume: 7 | Issue: 3 | Pages: 280-292

10.1016/j.jalz.2011.03.003 | PMID 21514248 Get It

The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia. This long “preclinical” phase of AD would provide a critical opportunity for therapeutic intervention; however, we need to further elucidate the link between the pathological cascade of AD and the emergence of clinical symptoms. The National Institute on Aging and the Alzheimer's Association convened an international workgroup to review the biomarker, epidemiological, and neuropsychological evidence, and to develop recommendations to determine the factors which best predict the risk of progression from “normal” cognition to mild cognitive impairment and AD dementia. We propose a conceptual framework and operational research criteria, based on the prevailing scientific evidence to date, to test and refine these models with longitudinal clinical research studies. These recommendations are solely intended for research purposes and do not have any clinical implications at this time. It is hoped that these recommendations will provide a common rubric to advance the study of preclinical AD, and ultimately, aid the field in moving toward earlier intervention at a stage of AD when some disease‐modifying therapies may be most efficacious.
Radiation Dose Reduction for CT-Guided Renal Tumor Cryoablation
Atwell, Thomas D. , Yu, Lifeng , Mandrekar, Jay , Lewis, Bradley, Woodrum, David A. , Leng, Shuai , Yu, Lifeng , McCollough, Cynthia H.

Mayo Clinic

American Journal of Roentgenology | April 21, 2011 | Volume: 196 | Issue: 5 | Pages: W586-W591

10.2214/ajr.10.5144 | PMID 21512049 Get It

Inappropriate Application of Nodule Management Guidelines in Radiologist Reports Before and After Revision of Exclusion Criteria
Feely, Meghan, Hartman, Thomas E.

Mayo Clinic

American Journal of Roentgenology | April 21, 2011 | Volume: 196 | Issue: 5 | Pages: 1115-1119

10.2214/ajr.10.5141 | PMID 21512078 Get It

Major Basic Protein from Eosinophils and Myeloperoxidase from Neutrophils Are Required for Protective Immunity to Strongyloides stercoralis in Mice
O’Connell, Amy E. , Hess, Jessica A., Santiago, Gilberto A. , Nolan, Thomas J. , Lok, James B. , Lee, James J. , Abraham, David , O'Connell, Amy E

Mayo Clinic

Infection and Immunity | April 12, 2011 | Volume: 79 | Issue: 7 | Pages: 2770-2778

10.1128/iai.00931-10 | PMID 21482685 Get It

ABSTRACTEosinophils and neutrophils contribute to larval killing during the primary immune response, and neutrophils are effector cells in the secondary response toStrongyloides stercoralisin mice. The objective of this study was to determine the molecular mechanisms used by eosinophils and neutrophils to control infections withS. stercoralis. Using mice deficient in the eosinophil granule products major basic protein (MBP) and eosinophil peroxidase (EPO), it was determined that eosinophils kill the larvae through an MBP-dependent mechanism in the primary immune response if other effector cells are absent. InfectingPHILmice, which are eosinophil deficient, withS. stercoralisresulted in development of primary and secondary immune responses that were similar to those of wild-type mice, suggesting that eosinophils are not an absolute requirement for larval killing or development of secondary immunity. TreatingPHILmice with a neutrophil-depleting antibody resulted in a significant impairment in larval killing. Naïve and immunized mice with neutrophils deficient in myeloperoxidase (MPO) infected withS. stercoralishad significantly decreased larval killing. It was concluded that there is redundancy in the primary immune response, with eosinophils killing the larvae through an MBP-dependent mechanism and neutrophils killing the worms through an MPO-dependent mechanism. Eosinophils are not required for the development or function of secondary immunity, but MPO from neutrophils is required for protective secondary immunity.
LIN28B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer
Permuth‐Wey, Jennifer, Tsai, Ya-Yu, Lin, Hui‐Yi , Chen, Y. Ann , Barnholtz‐Sloan, Jill S. , Birrer, Michael J. , Bloom, Gregory, Chen, Zhihua , Cunningham, Julie M. , Dagne, Getachew , Ebbert-Syfrett, Judith, Fenstermacher, David, García‐Closas, Montserrat , Gayther, Simon A. , Bosquet, Jesús González , Goode, Ellen L. , Iversen, Edwin S., Kong, William, McLaughlin, John, Menon, Usha , Monteiro, Álvaro N.A. , Narod, Steven A., Phelan, Catherine M., Qu, Xiaotao , Ramus, Susan J. , Schildkraut, Joellen M. , Song, Honglin , Stockwell, Heather, Sutphen, Rebecca , Terry, Kathryn L. , Vierkant, Robert A. , Wentzensen, Nicolas , Lancaster, Johnathan M., Cheng, Jin Q. , Sellers, Thomas A. , Kim, Donghwa , Chanock, Stephen Jacob , Cramer, Daniel W. , Fridley, Brooke L. , Ge, William H. , Gentry‐Maharaj, Aleksandra , Jim, Heather , McLaughlin, John, Pharoah, Paul D.P. , Risch, Harvey A. , Tyrer, Jonathan P. , Ramus, Susan J , Vierkant, Robert A , Menon, Usha , Monteiro, Alvaro N , Barnholtz-Sloan, Jill S , Lin, Hui-Yi , García-Closas, Montserrat , Bosquet, Jesus Gonzalez

Mayo Clinic

Cancer Research | April 12, 2011 | Volume: 71 | Issue: 11 | Pages: 3896-3903

10.1158/0008-5472.can-10-4167 | PMID 21482675 Get It

Abstract Defective microRNA (miRNA) biogenesis contributes to the development and progression of epithelial ovarian cancer (EOC). In this study, we examined the hypothesis that single nucleotide polymorphisms (SNP) in miRNA biogenesis genes may influence EOC risk. In an initial investigation, 318 SNPs in 18 genes were evaluated among 1,815 EOC cases and 1,900 controls, followed up by a replicative joint meta-analysis of data from an additional 2,172 cases and 3,052 controls. Of 23 SNPs from 9 genes associated with risk (empirical P < 0.05) in the initial investigation, the meta-analysis replicated 6 SNPs from the DROSHA, FMR1, LIN28, and LIN28B genes, including rs12194974 (G>A), an SNP in a putative transcription factor binding site in the LIN28B promoter region (summary OR = 0.90, 95% CI: 0.82–0.98; P = 0.015) which has been recently implicated in age of menarche and other phenotypes. Consistent with reports that LIN28B overexpression in EOC contributes to tumorigenesis by repressing tumor suppressor let-7 expression, we provide data from luciferase reporter assays and quantitative RT-PCR to suggest that the inverse association among rs12194974 A allele carriers may be because of reduced LIN28B expression. Our findings suggest that variants in LIN28B and possibly other miRNA biogenesis genes may influence EOC susceptibility. Cancer Res; 71(11); 3896–903. ©2011 AACR.
Cerebral Vascular Autoregulation and CO 2 Reactivity following Onset of the Delayed Postischemic Hypoperfusion State in Dogs
Christopherson, Thomas J., Milde, James H., Michenfelder, John D.

Mayo Clinic

Journal of Cerebral Blood Flow & Metabolism | April 8, 2011 | Volume: 13 | Issue: 2 | Pages: 260-268

10.1038/jcbfm.1993.32 | PMID 8436617 Get It

A small number of animal studies have suggested that during the delayed postischemic hypoperfusion state, CO 2 reactivity of the cerebral vasculature is lost whereas autoregulation is retained. These findings, however, are inconsistent with the bulk of experimental evidence which demonstrates that CO 2 reactivity is more robust and may be retained in pathologic circumstances which abolish autoregulation. These opposing viewpoints were therefore further evaluated in 18 dogs in which complete global ischemia was induced by cerebrospinal fluid (CSF) compression for periods of 12 ( n = 12) and 18 ( n = 6) min. Following 45 min of reperfusion and with onset of the delayed postischemic hypoperfusion state, autoregulation and CO 2 reactivity were evaluated using a continuous measurement of CBF (by sagittal sinus outflow). CO 2 reactivity was tested over a P a co 2 range of 20 to 60 mm Hg; autoregulation was tested over a blood pressure range of 60 to 140 mm Hg. Results demonstrated that after both 12 and 18 min of complete global ischemia, autoregulation and CO 2 reactivity of the cerebral vasculature were both present, but attenuated. In the case of CO 2 reactivity, the slope of the CBF response was decreased approximately 75%. In the case of autoregulation, the response in some dogs was incomplete as compared with their preischemic response.
Noncanonical K27-Linked Polyubiquitination of TIEG1 Regulates Foxp3 Expression and Tumor Growth
Peng, Dong-Jun , Zeng, Minghui , Muromoto, Ryuta , Matsuda, Tadashi , Subramaniam, Malayannan , Spelsberg, Thomas C., Wei, Wei‐Zen , Venuprasad, K. , Shimoda, Kazuya

Mayo Clinic

The Journal of Immunology | April 7, 2011 | Volume: 186 | Issue: 10 | Pages: 5638-5647

10.4049/jimmunol.1003801 | PMID 21471442 Get It

Abstract Earlier, we demonstrated the essential role of Kruppel-like transcription factor, TIEG1, in TGF-β–induced regulatory T cell (Treg) development. In this article, we demonstrate that IL-6, which promotes Th17 development, abrogated TIEG1 nuclear translocation and inhibited TGF-β–induced Treg development. Tyrosine kinase Tyk2-mediated phosphorylation of TIEG1 at Tyr179 promoted noncanonical K-27–linked polyubiquitination, which inhibited TIEG1 nuclear translocation. To test the role of TIEG1-regulated Treg/Th17 development in antitumor immunity, we analyzed TRAMP-C2 tumor growth in TIEG1−/− mice. The defective Treg development and elevated Th17 response resulted in enhanced immune reactivity in the tumor and inhibition of TRAMP-C2 tumor growth in TIEG1−/− mice. Thus, our results uncovered a novel regulatory mechanism that modulates Tregs and may regulate tumor progression.
Self Diagnosis of Lynch Syndrome Using Direct to Consumer Genetic Testing: A Case Study
Roberts, Maegan E. , Riegert‐Johnson, Douglas L. , Thomas, Brittany C. , Roberts, Maegan E

Mayo Clinic

Journal of Genetic Counseling | March 29, 2011 | Volume: 20 | Issue: 4 | Pages: 327-329

10.1007/s10897-011-9356-y | PMID 21448764 Get It

AbstractWe are reporting what we believe to be the first published case of patient initiated direct to consumer (DTC) genetic testing to test for the presence of a known familial mutation. Our client in this case is from a known MSH2 family; both his/her parent and associated grandparent have previously tested positive for the known familial MSH2 mutation. Using 23andme's “family inheritance genome‐wide comparison” option we were able to determine that our client most likely inherited the known familial MSH2 mutation without pursuing single site genetic testing. Our client pursued DTC genetic testing instead of single site genetic testing due to the fear of genetic discrimination. This case shows that patients are still fearful of genetic discrimination, despite the passage of the Genetic Information Nondiscrimination Act (GINA), and that DTC genetic testing may be useful despite the overall negative feeling towards this type of testing in the genetic counseling community.
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Systematic Overview
Nassar, Adrienne A., Jaroszewski, Dawn E. , Helmers, Richard A. , Colby, Thomas V. , Patel, B. M. , Mookadam, Farouk

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | March 25, 2011 | Volume: 184 | Issue: 1 | Pages: 8-16

10.1164/rccm.201010-1685pp | PMID 21471097 Get It

Abstract Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is being recognized with increasing frequency. Diagnostic and treatment information is limited. A systematic review is presented, focusing on patient demographics, clinical presentation, diagnosis, treatment options, and outcomes. A systematic electronic literature search was conducted for adult DIPNECH cases reported in the English literature during the past 6 years. Twenty-four DIPNECH cases were identified. Another case from our institution is contributed. Women represent 92% (23 of 25). Mean age at diagnosis was 58 years (range, 36–76 yr). Most were nonsmokers (16 of 24). Symptoms included cough (71%), dyspnea (63%), and wheezing (25%) occurring days to years before diagnosis. Pulmonary function testing showed obstructive ventilatory disease in 54%. Lung nodules were seen in 15 patients (63%), ground-glass attenuation in 7 patients (29%), and bronchiectasis in 5 patients (21%). Histological confirmation required surgical lung biopsy for 88%; however, transbronchial biopsies alone were diagnostic in three patients. Treatments strategies included systemic and inhaled corticosteroids, bronchodilators, and lung resection. Available follow-up data in 17 patients showed 6 clinically improved, 7 who remained stable, and 4 clinically deteriorated. The majority of patients presenting with DIPNECH are middle-aged females with symptoms of cough and dyspnea; obstructive abnormalities on pulmonary function testing; and radiographic imaging showing pulmonary nodules, ground-glass attenuation, and bronchiectasis. In general, the clinical course remains stable; however, progression to respiratory failure does occur. Long-term follow-up and treatment remains incomplete. Establishment of a national multicenter DIPNECH registry would allow formulation of optimal evidence-based guidelines for management of these patients.
Concerted Action of Aldehyde Dehydrogenases Influences Depot-Specific Fat Formation
Reichert, Barbara , Yasmeen, Rumana, Jeyakumar, Shanmugam M. , Yang, Fangping , Thomou, Thomas , Alder, Hansjüerg, Duester, Gregg , Maiseyeu, Andrei , Mihai, Georgeta, Harrison, Earl H. , Rajagopalan, Sanjay , Kirkland, James L. , Ziouzenkova, Ouliana

Mayo Clinic

Molecular Endocrinology | March 25, 2011 | Volume: 25 | Issue: 5 | Pages: 799-809

10.1210/me.2010-0465 | PMID 21436255 Get It

Abstract Vitamin A metabolite retinoic acid (RA) regulates life-sustaining differentiation processes and metabolic homeostasis. The aldehyde dehydrogenase-1 (Aldh1) family of enzymes (Aldh1a1, a2, and a3) catalyzes RA production from retinaldehyde and thereby controls concentrations of this transcriptionally active metabolite. The hierarchy of Aldh1 functions in adipose tissue has not been elucidated. We hypothesized that Aldh1 enzymes produce endogenous RA and regulate adipogenesis and fat formation in a fat depot-specific manner. We demonstrate that adipogenesis in vitro is accompanied by RA production generated primarily by Aldh1a1. In Aldh1a1-deficient adipocytes, adipogenesis is impaired compared with wild-type adipocytes due to markedly reduced expression of PPARγ regulated through zinc-finger protein 423 (ZFP423)-dependent mechanisms. These effects were recovered to some extent either by RA stimulation or overexpression of any of the Aldh1 enzymes in Aldh1a1−/− cells arguing that Aldh1a1 plays a dominant role in autocrine RA production. In vivo studies in C57/BL6 and Aldh1a1−/− mice on a regular diet revealed that multiple Aldh1 enzymes regulate differences in the formation of sc and visceral fat. In Aldh1a1−/− mice, visceral fat essentially lacked all Aldh1 expression. This loss of RA-producing enzymes was accompanied by 70% decreased expression of ZFP423, PPARγ, and Fabp4 in visceral fat of Aldh1a1−/−vs. wild-type mice and by the predominant loss of visceral fat. Subcutaneous fat of Aldh1a1−/− mice expressed Aldh1a3 for RA production that was sufficient to maintain expression of ZFP423 and PPARγ and sc fat mass. Our data suggest a paradigm for regulation of fat depots through the concerted action of Aldh1 enzymes that establish RA-dependent tandem regulation of transcription factors ZFP423 and PPARγ in a depot-specific manner.